Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Bermuda.
Press releases published on August 21, 2025
L’intervention de la Croix-Rouge en réponse aux feux de forêt de 2025 est la plus vaste des dernières années au pays
GlobeNewswire
·
August 21, 2025
OTTAWA, 21 août 2025 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne a annoncé aujourd’hui que les opérations en réponse aux feux de forêt de 2025 sont les plus vastes menées au pays au cours des dernières années. Depuis mai, la Croix-Rouge a offert de l’ …
Akebia Therapeutics and Innovative Renal Care Announce Nationwide Availability of Vafseo® (vadadustat) Across All IRC Dialysis Clinics
GlobeNewswire
·
August 21, 2025
CAMBRIDGE, Mass. and FRANKLIN, Tenn., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, and Innovative Renal Care (IRC), a …
Septerna Announces Dosing of the First Participants in Phase 1 Clinical Trial of SEP-631, an Oral Small Molecule MRGPRX2 Negative Allosteric Modulator for the Treatment of Mast Cell-Driven Diseases
GlobeNewswire
·
August 21, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced the dosing of the first …
Synergy CHC Corp to Present at the 2025 Gateway Conference on September 4th
GlobeNewswire
·
August 21, 2025
WESTBROOK, Maine, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, is confirmed to present at the 2025 Annual Gateway Conference, which is being held September …
Immuneering Announces $25 Million Private Placement
GlobeNewswire
·
August 21, 2025
CAMBRIDGE, Mass., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced that it has entered into a definitive securities purchase agreement for …
Chemomab Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 21, 2025
TEL AVIV, Israel, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that …
VeonGen Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for VG801 Gene Therapy for Stargardt Disease
GlobeNewswire
·
August 21, 2025
MUNICH, Aug. 21, 2025 (GLOBE NEWSWIRE) -- VeonGen Therapeutics, a clinical-stage genetic medicine company developing next-generation gene therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced …
Catheter Precision Announces the Start of Enrollment for the LockeT Compare Study
GlobeNewswire
·
August 21, 2025
Fort Mill, S.C., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market today announced that the …
BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.
GlobeNewswire
·
August 21, 2025
This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home Neurolief’s breakthrough Proliv™Rx device is pending Premarket Approval from the U.S. FDA, and if granted …
Pyxis Oncology to Participate in September Investor and Industry Conferences
GlobeNewswire
·
August 21, 2025
BOSTON, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing antibody-drug conjugate (ADC) therapeutics for difficult-to-treat cancers, today announced that Lara S. Sullivan, M.D., President, Chief …
InflaRx Announces Participation in September Investor Conferences
GlobeNewswire
·
August 21, 2025
JENA, Germany, Aug. 21, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced it will participate in two investor conferences in …
2025 Buyers Guide: MushCanyon Announces 2025 Launch of Functional Mushroom Gummies for Focus, Calm, and Whole-Body Wellness
GlobeNewswire
·
August 21, 2025
New York , Aug. 21, 2025 (GLOBE NEWSWIRE) -- MushCanyon today announced the release of its Functional Mushroom Gummies, a clean-label supplement created for modern consumers seeking natural solutions to support focus, stress relief, immune balance, and …
DiamiR Biosciences and Aptorum Group Announce New York State Approval for DiamiR’s APOE Genotyping Test
GlobeNewswire
·
August 21, 2025
NEW YORK, NY, NEW HAVEN, CT, and PRINCETON, N.J., Aug. 21, 2025 (GLOBE NEWSWIRE) -- DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, and Aptorum Group Limited (NASDAQ: APM) (" …
Kraig Biocraft Laboratories Announces Commencement of Full Operations at Second Production Rearing Center in Southeast Asia
GlobeNewswire
·
August 21, 2025
ANN ARBOR, Mich., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, announces that its second production rearing center in Southeast Asia is now fully …
BioCryst to Present at Upcoming Investor Conference
GlobeNewswire
·
August 21, 2025
RESEARCH TRIANGLE PARK, N.C., Aug. 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the Cantor Global Healthcare Conference in New York on Thursday, September 4, 2025, at 9:45 a …
Evoke Pharma Announces Listing of New GIMOTI® Patent in FDA Orange Book
GlobeNewswire
·
August 21, 2025
SOLANA BEACH, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today …
Castle Biosciences to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 21, 2025
FRIENDSWOOD, Texas, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company …
Skye Bioscience to Participate in Upcoming Investment and Medical Conferences
GlobeNewswire
·
August 21, 2025
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that it will …
Unleashing the Spirit of Adventure: Breckenridge Distillery Launches Mountain Shot, a Bold New Mushroom-Infused Elixir
GlobeNewswire
·
August 21, 2025
BRECKENRIDGE, Colo., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is thrilled to announce its latest innovation, Mountain Shot, a crafted …
I-Mab to Participate in September Investor Conferences
GlobeNewswire
·
August 21, 2025
ROCKVILLE, Md., Aug. 21, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that I-Mab’s …